W. R. Berkley
WRB
$69.14
-0.52%
W.R. Berkley Corporation is an insurance holding company that underwrites commercial casualty insurance through its subsidiaries, specializing in niche products such as excess and surplus lines, workers' compensation, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses. As a specialist in the property and casualty insurance sector, W.R. Berkley differentiates itself through disciplined underwriting and a focus on underserved, specialized markets, positioning it as a niche player with a strong reputation for profitability. The current investor narrative centers on the company's ability to maintain underwriting discipline and profitability amid a competitive insurance market, with recent attention on its financial performance and strategic positioning as it navigates changing market conditions and potential regulatory or economic headwinds.…
WRB
W. R. Berkley
$69.14
Related headlines
WRB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on W. R. Berkley's 12-month outlook, with a consensus price target around $69.53 and implied upside of +0.6% versus the current price.
Average Target
$69.53
0 analysts
Implied Upside
+0.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$51 - $83
Analyst target range
W.R. Berkley is covered by 17 analysts, with a consensus recommendation of 'hold' and a mean recommendation score of 3.39 (where 1 is strong buy and 5 is sell). The average target price is $69.53, which is nearly identical to the current price of $69.14, implying a negligible upside of 0.56%. The distribution includes 1 buy, 10 holds, and 6 sells, indicating a cautious sentiment among analysts. The low target is $51.00, representing a downside of 26.2%, while the high target is $83.00, implying an upside of 20.0%. The wide spread between the low and high targets (a 62.7% difference) reflects significant uncertainty about the company's future performance. Recent ratings actions show a mix of upgrades and downgrades, with Goldman Sachs upgrading to Buy in June 2026, while Wells Fargo downgraded to Underweight, indicating divergent views on the stock's prospects.
WRB Technical Analysis
W.R. Berkley's stock has been in a broad range-bound consolidation over the past year, with a 1-year price change of -5.18%, reflecting a slight downtrend. The current price of $69.14 sits at 45.8% of the 52-week range (between $62.87 low and $78.96 high), indicating the stock is closer to the lower end of its range, which could suggest a value opportunity or reflect ongoing bearish sentiment. The stock's beta of 0.283 indicates it is significantly less volatile than the broader market, which may appeal to risk-averse investors but also implies lower sensitivity to market rallies.
Beta
0.28
0.28x market volatility
Max Drawdown
-19.0%
Largest decline past year
52-Week Range
$63-$79
Price range past year
Annual Return
-5.2%
Cumulative gain past year
| Period | WRB Return | S&P 500 |
|---|---|---|
| 1m | -4.1% | -0.4% |
| 3m | +0.8% | +4.2% |
| 6m | -1.1% | +13.7% |
| 1y | -5.2% | +19.0% |
| ytd | -0.3% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WRB Fundamental Analysis
W.R. Berkley's revenue has shown steady growth, with the most recent quarter (Q1 2026) reporting revenue of $3.69 billion, up 3.98% year-over-year. Over the past five quarters, revenue has grown from $3.40 billion in Q3 2024 to $3.69 billion in Q1 2026, indicating a consistent but moderate growth trajectory. The company's net income for Q1 2026 was $515 million, with a net margin of 13.97%, reflecting strong profitability. Gross margin for the quarter was 47.51%, which is robust for the insurance industry, and operating margin stood at 16.70%, demonstrating efficient cost management. The company's ROE is 18.34%, and ROA is 3.56%, indicating effective use of equity and assets to generate profits.
Quarterly Revenue
$3.7B
2026-03
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
47.5%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WRB Overvalued?
Given that W.R. Berkley has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 15.65x, while the forward PE is 14.28x, indicating that the market expects earnings growth, as the forward multiple is lower. This gap suggests a positive growth outlook, with the forward PE implying a 9.6% earnings increase. Compared to the industry average PE of 15x (as per valuation data), W.R. Berkley trades at a slight premium of 4.3%, which may be justified by its superior ROE of 18.34% versus the industry average of 12%. Historically, the stock's PE has ranged from 7.8x to 26.5x over the past five years, with the current trailing PE of 15.65x sitting near the midpoint, suggesting the stock is fairly valued relative to its own history.
PE
15.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.9x
Enterprise Value Multiple